Latest Information

Below you can access the latest press releases, financial reports, corporate governance documents and more. Please note that some documents may refer to Liminal BioSciences' previous name Prometic Life Sciences Inc.

  • LMNL Corporate Presentation November

    LMNL Corporate Presentation November

    Read PDF
  • Liminal BioSciences Receives FDA Approval for its US-based Plasma Collection Center

    Liminal BioSciences Receives FDA Approval for its US-based Plasma Collection Center

    Prometic Plasma Resources (USA) Inc., has received U.S. Food and Drug Administration (“FDA”) approval for its plasma collection center located in Amherst, NY.

    Read Article
  • Liminal BioSciences Announces First Subject Dosed in Phase 1 Multiple Ascending Dose Clinical Trial of Fezagepras

    Liminal BioSciences Announces First Subject Dosed in Phase 1 Multiple Ascending Dose Clinical Trial of Fezagepras

    LMNL today announced that the first subject has been dosed in the Company’s fezagepras Phase 1 multiple ascending dose clinical trial in healthy volunteers.

    Read Article
  • Liminal BioSciences Presents Two Case Histories on Investigational Intravenous Plasminogen (Human) Replacement Therapy at The ASH Conference

    Liminal BioSciences Presents Two Case Histories on Investigational Intravenous Plasminogen (Human) Replacement Therapy at The ASH Conference

    LMNL announced the presentation of two scientific posters highlighting potential activity of intravenous Ryplazim® (plasminogen) on infertility and acute airway obstruction in patients with C-PLGD.

    Read Article

  • Press Releases

    Read More
  • Quarterly Report Q3 2020

    Quarterly Report Q3 2020

    Read PDF
  • Quarterly Report Q2 2020

    Quarterly Report Q2 2020

    Read PDF
  • Quarterly Report Q1 2020

    Quarterly Report Q1 2020

    Read PDF

  • Financial Reports

    Read Now
  • Board Committees - Chairs' Mandate 2020

    Board Committees - Chairs' Mandate 2020

    Read PDF
  • ×

    Get the updates before everyone else.

    First Name
    Last Name
    * By completing and submitting this form, you understand and agree that use of Liminal BioSciences' web site is subject to Liminal BioSciences Privacy Policy
    !
    Thank you!
    Error - something went wrong!
  • Mandate of the Chair of the Board 2020

    Mandate of the Chair of the Board 2020

    Read PDF

  • LMNL Share Price

    View Now
  • CEO Position Description 2020

    CEO Position Description 2020

    Read PDF

  • Corporate Governance

    Read More
  • loading
    Loading More...